.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,732,595

« Back to Dashboard

Details for Patent: 7,732,595

Title:Process for preparing an A.sub.2A-adenosine receptor agonist and its polymorphs
Abstract: Disclosed is a synthesis suitable for large scale manufacture of an A.sub.2A-adenosine receptor agonist, and also relates to polymorphs of that compound, and to methods of isolating a specific polymorph. The A.sub.2A-adenosine receptor agonist has the following formula: ##STR00001## This compound is prepared by reacting the ethyl ester with methylamine in a sealed pressure reactor.
Inventor(s): Zablocki; Jeff (Mountain View, CA), Elzein; Elfatih (Fremont, CA)
Assignee: Gilead Palo Alto, Inc. (Foster City, CA)
Filing Date:Feb 02, 2007
Application Number:11/701,699
Claims:1. A method for the large scale preparation of (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminop- urin-2-yl}pyrazol-4-yl)-N-methylcarboxamide: ##STR00025## comprising: reacting a compound of the formula (3) ##STR00026## with methylamine wherein the compound of formula (3) is reacted with an aqueous solution of methylamine at an initial temperature of about 0-5.degree. C. followed by warming to about 50-70.degree. C. in a sealed pressure reactor.

2. The method of claim 1, further comprising wherein the (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminop- urin-2-yl)pyrazol-4-yl)-N-methylcarboxamide end product is isolated as the pure monohydrate by (a) dissolving the product in a solvent, (b) adding purified water, (c) filtering the slurry thus formed, (d) washing the contents of the filter with water followed by ethanol, and (e) drying the solid that remains under vacuum at a temperature that does not exceed 40.degree. C.

3. The method of claim 2, wherein the solvent of step (a) is dimethylsulfoxide.

4. A method of preparing a compound of the formula (3): ##STR00027## comprising: reacting a compound of the formula (2) ##STR00028## with ethyl 2-formyl-3-oxopropionate wherein about 1.1 molar equivalent of ethyl 2-formyl-3-oxopropionate is reacted with the compound of formula (2) in a solvent.

5. The method of claim 4, wherein the solvent is ethanol.

6. The method of claim 5, wherein the reaction is conducted at a temperature of about 80.degree. C.

7. A method of synthesizing (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminop- urin-2-yl}pyrazol-4-yl)-N-methylcarboxamide ##STR00029## comprising by contacting a compound of the formula (4): ##STR00030## with an aqueous solution of methylamine at an initial temperature of about 0-5.degree. C. followed by warming to about 50-70.degree. C. in a sealed pressure reactor.

8. The method of claim 7, further comprising wherein the (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminop- urin-2-yl}pyrazol-4-yl)-N-methylcarboxamide end product is isolated as the pure monohydrate by (a) dissolving the product of claim 7 in a solvent, (b) adding purified water, (c) filtering the slurry thus formed, (d) washing the contents of the filter with water followed by ethanol, and (e) drying the solid that remains under vacuum at a temperature that does not exceed 40.degree. C.

9. The method of claim 8, wherein the solvent of step (a) is dimethylsulfoxide.

10. A method of synthesizing a compound of the formula (4): ##STR00031## comprising contacting a compound of the formula (2): ##STR00032## with an excess of ethyl 2-formyl-3-oxopropionate wherein about a 2-10 fold molar excess of ethyl 2-formyl-3-oxopropionate is reacted with the compound of the formula (2) in a solvent.

11. The method of claim 10, wherein the solvent is ethanol.

12. The method of claim 11 wherein the reaction is conducted at a temperature of about 80.degree. C.

13. The method of claim 10, wherein about a 5-10 fold molar excess of ethyl 2-formyl-3-oxopropionate is reacted with the compound of the formula (2).
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc